Kemwell Biopharma Private Limited - Company Profile

It is a pharma private limited company based in Bangalore, Karnataka, India, established in 2008.

2008 Bangalore, Karnataka, India Active

Last Updated: December 18, 2025

About Kemwell Biopharma Private Limited

Kemwell Biopharma Private Limited, a active private limited company, was established on 07 May 2008 in Bangalore, Karnataka, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24232KA2008PTC046341. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹240.00 Cr and a paid-up capital of ₹5.13 Cr.

It upholds a compliant status. Employing 296 professional, Its leadership includes Anurag Bagaria (Director), Neha Anurag Bagaria (Director). Past directors included Rolf Guenter Werner, Karan Bagaria, Suresh Nagappa Ganachari. It holds ₹50.00 Cr open charges and ₹250.11 Cr settled loans. Its latest AGM occurred on 27 September 2024, with the balance sheet filed on 31 March 2024. It is based at Kemwell House No.11, Tumkur Road, Bangalore, Karnataka, 560022.

Company Details

CIN/LLPIN
U24232KA2008PTC046341
Registration Number
046341
Incorporation Date
07 May 2008
Authorized Capital
₹240.00 Cr
Paid-Up Capital
₹5.13 Cr
ROC Code
Roc Bangalore
Listing Status
Unlisted
Company Status
Active

Key Metrics

Authorised Capital ₹ 240.00 Cr as on 18-12-2025
Paid Up Capital ₹ 5.13 Cr as on 18-12-2025
Company Age 17 Year, 9 Months
Last Filing with ROC 31 Mar 2024
Open Charges ₹ 50.00 Cr as on 18-12-2025
Satisfied Charges ₹ 250.11 Cr as on 18-12-2025
Revenue Growth **** 49.48% (FY 2024)
Profit Growth **** 1500.87% (FY 2024)
Ebitda **** 352.80% (FY 2024)
Net Worth 13.57% (FY 2024)
Total Assets **** 13.12% (FY 2024)

Comprehensive Company Insights

Explore comprehensive insights into Kemwell Biopharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Kemwell Biopharma Private Limited?

Current Directors

Name	Designation	Appointment Date	Status
Anurag Bagaria	Director	07 May 2008	Current
Neha Anurag Bagaria	Director	21 Jun 2024	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Director	20 Aug 2018	Past
Pramod Abcsdd	Managing Director	28 Dec 2017	Past
Pramod Abcsdd	Company Secretary	15 Feb 2017	Past
Pramod Abcsdd	Company Secretary	-	Past
Pramod Abcsdd	Managing Director	22 Feb 2017	Past
Pramod Abcsdd	Company Secretary	08 Dec 2011	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Kemwell Biopharma.

Kemwell Biopharma Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 49.48% increase. The company also saw a substantial improvement in profitability, with a 1500.87% increase in profit. The company's net worth Soared by an impressive increase of 13.57%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

49.48%

*******

Revenue from Operations

*******

49.73%

*******

Total Assets

*******

13.12%

*******

Profit or Loss

*******

1500.87%

*******

Net Worth

*******

13.57%

*******

EBITDA

*******

352.80%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Kemwell Biopharma?

In 2024, Kemwell Biopharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹500,000,000.00

Satisfied Charges

₹2,501,100,000.00

Charges Breakdown by Lending Institutions

Others : 50.00 Cr

Latest Charge Details

Date	Lender	Amount	Status
01 Aug 2024	Others	₹50.00 Cr	Open
31 Mar 2012	Citi Bank N.A.	₹4.75 Cr	Satisfied
20 Jul 2011	State Bank Of India	₹220.07 Cr	Satisfied
17 May 2011	State Bank Of India	₹25.29 Cr	Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Kemwell Biopharma?

Kemwell Biopharma has a workforce of 296 employees as of Mar 18, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Kemwell Biopharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kemwell Biopharma's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Kemwell Biopharma

Recent Activity within the Organization

Annual General Meeting

The activity Kemwell Biopharma Private Limited last Annual general meeting of members was held on 27 Sep 2024 as per latest MCA records. was completed.
27 Sep 2024
Charges

A charge with Others amounted to Rs. 50.00 Cr with Charge ID 100965602 was registered on 01 Aug 2024. was recorded as a recent event.
01 Aug 2024
Director Appointment

The activity Neha Anurag Bagaria was appointed as a Director was appointed as a Director on 21 Jun 2024 & has been associated with this company since 1 year 8 months . was completed.
21 Jun 2024
Balance Sheet

The activity Kemwell Biopharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Bangalore. was completed.
31 Mar 2024
Charges

The activity A charge registered on 20 Jul 2011 via Charge ID 10302908 with State Bank Of India was fully satisfied on 29 Jul 2019. was completed.
29 Jul 2019
Charges

The activity A charge registered on 17 May 2011 via Charge ID 10292583 with State Bank Of India was fully satisfied on 26 Feb 2016. was completed.
26 Feb 2016

Explore recent activity and updates - View Recent Activity